Metastasising pituitary neuroendocrinal tumour with peptide secretion

Journal of Association of Physicians of India

Volumn 52, Issue JAN, 2004, Pages 74-75

  Harinarayan, C V ^a   Reddy, K ^a  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE;

ADULT; ARTICLE; CARCINOMA; CASE REPORT; HUMAN; HYPOPHYSIS TUMOR; LIVER TUMOR; MALE; METABOLISM; METASTASIS; PATHOLOGY; PROLACTINOMA; SECRETION; STOMACH TUMOR;

ADULT; CARCINOMA, NEUROENDOCRINE; HUMANS; LIVER NEOPLASMS; MALE; PEPTIDES; PITUITARY NEOPLASMS; PROLACTINOMA; STOMACH NEOPLASMS;

EID: 13744257055     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Burrow GN, Wortzman G, Rewcastle NB, et al. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156-58.
2. Maurer RA. Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem 1980;255:8092-97.
3. Walker JD, Grossman A, Anderson V, et al. Malignant prolactinoma with extracranial metastases. A report of three cases. Clin Endocrinol (Oxf) 1993;38:411-19.
4. Cai WY, Alexander JM, Hedley-Whyte ET, et al. Ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab 1994;78:89=93.
5. Thapar K, Scheithauer BW, Kovacs K, et al. p53 expression in pituitary adenomas and carcinomas. Correlation with invasiveness and tumour growth fractions. Neurosurgery 1996;38:765-71.
6. Molitch ME. Pathologic prolactinomas. Endocrinol Metab Clin N Am 1992;21:877.